Related Experiment Videos
The future--can we learn from the past?
1William S. Middleton Memorial VA Hospital, Madison, WI 53705, USA.
Abstract:
We know that the current problems of resistance among bacterial pathogens to commonly prescribed antibiotics is, in part, attributable to inappropriate prescribing. If we are to rectify matters, we must learn from past mistakes and take appropriate measures to ensure that community-acquired infections do not become as untreatable as certain nosocomial infections are now. This means that we must be able to predict efficacy outcomes better so that we can make more effective use of available antibiotics. Animal studies suggest that the duration of time that an antibiotic exceeds the MIC of the causative pathogen (i.e., at least 40 to 50% of the dosing interval) is a good prognostic indicator for the efficacy of beta-lactam antibiotics. Clinical studies are now being published that confirm the value of time above MIC. Use of this information should enhance efficacy and may delay the pace of developing antibiotic resistance, allowing time for new antimicrobial agents to be researched and brought to market.
Insights
Antibiotic resistance is a growing problem, partly due to incorrect prescribing. Optimizing antibiotic use by monitoring time above the minimum inhibitory concentration (MIC) can improve treatment effectiveness and slow resistance.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotic resistance in bacterial pathogens is a significant global health threat.
- Inappropriate antibiotic prescribing contributes to the rise of untreatable infections.
- Predicting antibiotic efficacy is crucial for effective treatment and resistance management.
Purpose of the Study:
- To evaluate the clinical value of 'time above minimum inhibitory concentration' (T>MIC) as a predictor of antibiotic efficacy.
- To explore strategies for optimizing antibiotic use in community-acquired infections.
- To investigate methods for delaying the development of antibiotic resistance.
Main Methods:
- Review of animal studies and clinical trials investigating pharmacokinetic/pharmacodynamic (PK/PD) parameters.
- Analysis of data correlating T>MIC with treatment outcomes for beta-lactam antibiotics.
- Assessment of the potential impact of T>MIC-guided therapy on antibiotic resistance.
Main Results:
- Animal studies indicate that maintaining antibiotic levels above the MIC for 40-50% of the dosing interval predicts efficacy for beta-lactam antibiotics.
- Emerging clinical data support the value of T>MIC as a reliable indicator of treatment success.
- Optimizing T>MIC can enhance the effectiveness of current antibiotic regimens.
Conclusions:
- Clinical application of T>MIC monitoring can improve patient outcomes for bacterial infections.
- Effective use of existing antibiotics, guided by T>MIC, may help mitigate the development of antibiotic resistance.
- This approach provides a critical window for research and development of novel antimicrobial agents.